Substance Use Disorders

What is Substance Use Disorders?

Substance Use Disorders are medical conditions where repeated substance use physically rewires three key brain systems: the reward pathway (basal ganglia), the stress system (extended amygdala), and the control center (prefrontal cortex), making willpower alone rarely sufficient for recovery. Approximately 10% of the population is affected, with sharply higher rates among neurodivergent individuals -- 25% of Autistic adults and 40% of ADHDers develop SUDs, often because substances temporarily ease sensory overload or focus challenges.

1 in 10people affected
10%prevalence
Normal IQ range

How does Substance Use Disorders present?

  • Continuing use despite losing jobs or relationships
  • Needing larger amounts to feel the same effect
  • Spending hours daily obtaining, using, or recovering from substances
  • Multiple unsuccessful attempts to quit despite genuine desire
  • Visible physical changes: weight loss, skin issues, tremors

Types of Substance Use Disorders

  • Alcohol Use Disorder(~35%)
  • Opioid Use Disorder(~20%)
  • Stimulant Use Disorder(~15%)
  • Cannabis Use Disorder(~20%)
  • Polysubstance Use(~60%)

Common questions about Substance Use Disorders

Can brain damage from substance use be reversed?

Yes, the brain shows remarkable neuroplasticity. Dopamine receptors regenerate 20-30% within 6 months of sobriety. Prefrontal cortex function improves steadily over 2-5 years.

Why do cravings persist years after quitting?

Substance memories get stored in the amygdala and basal ganglia through glutamate signaling. These regions trigger automatic cravings when encountering cues.

Content reviewed against DSM-5 criteria and current clinical literature. This page is for educational purposes and does not constitute medical advice. Consult a qualified healthcare professional for diagnosis or treatment.

Substance Use DisordersSubstance Use Disorders

Substance Use Disorders

Could this be me?

What actually is it?

Substance Use Disorders are medical conditions where repeated substance use physically rewires three key brain systems: the reward pathway (basal ganglia), the stress system (extended amygdala), and the control center (prefrontal cortex), making willpower alone rarely sufficient for recovery. Approximately 10% of the population is affected, with sharply higher rates among neurodivergent individuals -- 25% of Autistic adults and 40% of ADHDers develop SUDs, often because substances temporarily ease sensory overload or focus challenges.

Recovery is real and neurologically measurable: dopamine receptors regenerate 20-30% within six months of sustained sobriety.

People Around You

You may meet about 80,000 people in your life.

You may know about ... of them.

Of the people around you, how many might have substance use disorders?

Pick the closest guess.

It's a difference in how the brain is wired, not a character flaw.

PET imaging reveals 15-20% reduction in D2 dopamine receptors after chronic substance use, with 40% reduced ventral striatum activation to natural rewards -- measurable brain changes, not moral failures.

Volkow et al., NEJM (2016)
Tap to Start Myth Busting

How it looks vs. How it feels

The lived experience behind the observed behavior

Continuing use despite losing jobs or relationships — The Unstoppable Cost
Tap to see inside

What others see

Continuing use despite losing jobs or relationships

The Unstoppable Cost

On the inside

The Unstoppable Cost

I can see everything I'm losing - job, family, health - but my brain treats the substance as more essential than any of it. The prefrontal cortex is offline and the basal ganglia runs on autopilot toward the only reward it recognizes.

Needing larger amounts to feel the same effect — The Moving Baseline
Tap to see inside

What others see

Needing larger amounts to feel the same effect

The Moving Baseline

On the inside

The Moving Baseline

What used to get me high now just gets me to normal. My reward system recalibrated and I'm chasing a feeling that keeps retreating. Dopamine receptors have downregulated - my brain needs more input to reach the same signal strength.

Spending hours daily obtaining, using, or recovering from substances — The Narrowed World
Tap to see inside

What others see

Spending hours daily obtaining, using, or recovering from substances

The Narrowed World

On the inside

The Narrowed World

My entire day revolves around one thing. Getting it, using it, recovering from it. Everything else faded to background noise. The nucleus accumbens has reorganized my priorities so thoroughly that 'normal' life feels like static.

Multiple unsuccessful attempts to quit despite genuine desire — The Guilt Loop
Tap to see inside

What others see

Multiple unsuccessful attempts to quit despite genuine desire

The Guilt Loop

On the inside

The Guilt Loop

I hate what I'm doing while I'm doing it. I try to stop, I fail, the shame drives more use. Each attempt proves what my brain already believes. The extended amygdala makes sobriety feel physically unbearable, driving a cycle logic alone can't break.

Visible physical changes: weight loss, skin issues, tremors — The Visible Decline
Tap to see inside

What others see

Visible physical changes: weight loss, skin issues, tremors

The Visible Decline

On the inside

The Visible Decline

I can see the damage in the mirror. My body is keeping score of what my brain refuses to stop doing. The neuroadaptations that drive compulsive use are invisible, but their consequences write themselves across my face and body.

Waking up sick and needing to use before starting the day — The Withdrawal Clock
Tap to see inside

What others see

Waking up sick and needing to use before starting the day

The Withdrawal Clock

On the inside

The Withdrawal Clock

My body keeps a countdown I can't ignore. When the clock runs out, every cell screams for input. Sweating, shaking, nausea—the extended amygdala has made sobriety feel like physical danger. I'm not choosing to use first thing; I'm choosing to stop the pain.

Buprenorphine and methadone reduce all-cause mortality by 50% and opioid overdose deaths by 70%, while stabilizing -- not replacing -- opioid receptor function to allow neural repair.

Sordo et al., BMJ (2017)
Tap to Start Myth Busting